Epigenetics studies how chemical and structural changes to DNA and its associated proteins regulate gene activity without altering the underlying genetic code. These modifications help explain how cells with identical DNA develop into diverse types and how organisms respond flexibly to their environments.

A central focus is on epigenetic marks such as DNA methylation and modifications of histone proteins, which together shape chromatin structure. Tightly packed chromatin tends to silence genes, while more open regions promote gene expression. These mechanisms are critical during development, guiding cell differentiation and stabilizing cellular identity.

Environmental influences can alter epigenetic patterns. Diet, stress, toxins and lifestyle factors can reshape chromatin and methylation landscapes, sometimes with long lasting effects on physiology and disease risk. In some cases, epigenetic changes can be transmitted across cell divisions and occasionally across generations, contributing to phenotypic variation that is not strictly genetic.

Epigenetic dysregulation is implicated in many diseases, particularly cancer, where aberrant methylation and histone modification patterns disrupt normal control of cell growth and survival. This has opened avenues for diagnostics based on epigenetic biomarkers and for therapies that aim to reset aberrant marks using “epidrugs” targeting enzymes that write, erase or read these modifications.

Modern techniques such as genome wide methylation profiling, chromatin accessibility mapping and single cell epigenomics are revealing the fine scale complexity of epigenetic regulation. Together, these findings position epigenetics as a key bridge between the genome, the environment and observable traits, reshaping our understanding of heredity, development and disease.